Om

Rhelion Life Sciences Corp. is a life sciences company focused on the research, development, and commercialization of natural psychedelic medicines and related products. The company operates a pharmaceutical development platform through its subsidiary Filament Health, where it advances naturally derived psilocybin candidates for psychiatric and neurological conditions and supports clinical research and compassionate-use programs. In parallel, Rhelion participates in the legal adult-use market in the Netherlands, where it sells psilocybin truffles through regulated consumer channels. Based in Toronto, Canada, the company combines drug discovery, product development, and market participation within the emerging psychedelic sector, positioning itself at the intersection of healthcare innovation and regulated natural medicine development.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I RHELION LIFE SCIENCES MED ENDAVU: Køb Rhelion Life Sciences ($4YX0) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Rhelion Life Sciences, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.